Reaction: Treprostinil to 1 product

Reaction
Treprostinil
DB00374
    Treprostinil metabolite HU5
    DBMET03509
    Reaction type
    glucuronidation
    Direction
    Major circulating metabolite?
    No
    Spontaneous?
    No
    Activity
    inactive
    References
    1. FDA Pharmacology Review: REMODULIN (treprostinil) injection, for subcutaneous or intravenous use [Link]
    Comments
    Metabolite detected after subcutaneous infusion.
    Enzymes
    Not Available